Phase 1a clinical oncology trial with VGX-100 successfully completes patient enrolment
Oct 17, 2013
OTC Disclosure News Service
South Yarra, Victoria, Australia
This release includes additional documents. Select the link(s) below to view.
20131017 ASX October 18_Ceres_P1a_Press Release_Final.pdf
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.